CompaniesNeuMoDx Molecular

NeuMoDx Molecular

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

4,017

By Phase

NA: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
Funding History (5)
D
May 3, 2018
D
Mar 20, 2018
D
Apr 29, 2016
D
Mar 26, 2014
D
Apr 10, 2012
Related Companies
Qiagen
acquired